What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis

Conclusions. For commonly used cost-effectiveness benchmarks, maternal aP immunization would be cost-effective in many LMICs only if the vaccine were offered at less than $1–$2/dose.

Source: Clinical Infectious Diseases - November 11, 2016 Category: Infectious Diseases Authors: Russell, L. B., Pentakota, S. R., Toscano, C. M., Cosgriff, B., Sinha, A. Tags: INFANT PERTUSSIS DISEASE BURDEN IN THE CONTEXT OF MATERNAL IMMUNIZATION STRATEGIES Source Type: research